Market Cap 32.97B
Revenue (ttm) 15.46B
Net Income (ttm) 1.03B
EPS (ttm) N/A
PE Ratio 15.91
Forward PE 16.55
Profit Margin 6.66%
Debt to Equity Ratio 0.66
Volume 14,126,800
Avg Vol 42,494,879
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 50%
Beta 0.60
Analysts Sell
Price Target $19.00

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment...

Industry: Household & Personal Products
Sector: Consumer Defensive
Address:
1 Kenvue Way, Summit, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:50 PM
$KVUE Actionable Trade Alert: Market Context: $KVUE is currently trading at $17.21, showing a bullish sentiment as it is near its 60D high of $17.59. The RSI at 57.53 indicates that the stock is neither overbought nor oversold, suggesting room for upward movement. The MA30 at $16.92 and MA50 at $16.32 are both below the current price, reinforcing a bullish trend. Directional Bias: The stock is positioned well above its moving averages, indicating potential for continued upward momentum. With the recent high of $17.59, there is a clear target for profit-taking. Trade Plan: - Suggested Entry: $17.25 - Stop Loss: $16.75 (3% below entry) - Take Profit Targets: 1. $17.75 (2.9% gain) 2. $18.00 (4.3% gain) 3. $20.00 (16.5% gain) This plan offers a potential ROI of over 17% on the third target. Monitor the stock closely and adjust the stop loss as necessary. https://privateprofiteers.com
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 25 at 1:08 PM
no fomo on $KVUE - just waiting for H% to show low like usual
0 · Reply
Okadarlan
Okadarlan Dec. 25 at 11:24 AM
$KVUE Merry christmas everyone, vote against ... we dont need monopolies , i love the stock the way it is , the price and divi .. and their financials all are splended, nn no stupid merger, so all vote no please. Special Meeting of Kenvue Inc. Stockholders To be held at 9:00 a.m. Eastern Time on Thursday, January 29, 2026 Meeting Proposals Not Voted Vote by 11:59 p.m. ET on January 28, 2026 Documents to Review Before You Vote: Notice of Meeting ... Notice of Meeting and Proxy Statement(pdf) Please read the important information regarding this meeting agenda.
0 · Reply
nokej13957
nokej13957 Dec. 25 at 10:55 AM
0 · Reply
LaserLeverage
LaserLeverage Dec. 25 at 5:24 AM
$KVUE Future valuation dynamics revolve around resilience of demand as cyclical tailwinds fade, with outcomes shaped by timing and discipline. Failure to deliver could compress multiples quickly.
0 · Reply
1iquid
1iquid Dec. 25 at 3:33 AM
💎 Liquid® Live Actionable Trade Asset: $KVUE Contracts: $KVUE January 15, 2027 $18 Calls Scale in: $1.45- $1.77 Scale out: $5.63-$9.64 Profit Potential : 259% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
Suite510
Suite510 Dec. 25 at 3:20 AM
$JNJ $KVUE 1 Billion Bots 🤖 stupid lol 😂 Idiot corporate directors until they lose everything $JNJ $KVUE $SPY $SPX JNJ Insurance Company why pay millions on verdicts when you can pay Billions for 1 verdict 🤣🤓🍿
0 · Reply
Suite510
Suite510 Dec. 24 at 11:15 PM
$JNJ $KVUE Bear 🐻 ish can’t wait till 2026 😂🎅
0 · Reply
AbraKrak
AbraKrak Dec. 24 at 3:28 PM
$KMB Very happy with my buy @ 100 here. Not only is it undervalued, but a good hedge vs. any tech weakness. $KVUE
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Dec. 24 at 2:55 PM
$JNJ $KVUE $SPX $SPY FYI this account is a bot.
0 · Reply
Latest News on KVUE
Dividend Kings: 3 Ideal Buys In 56 For December

Dec 11, 2025, 5:50 PM EST - 14 days ago

Dividend Kings: 3 Ideal Buys In 56 For December

MO UBSI


Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out

Dec 5, 2025, 1:36 PM EST - 20 days ago

Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out


Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 26 days ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR


Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Nov 6, 2025, 8:06 AM EST - 7 weeks ago

Texas seeks to block Kenvue dividend amid Tylenol lawsuit


Watch These Stocks Falling 10% Or More

Nov 4, 2025, 4:58 PM EST - 7 weeks ago

Watch These Stocks Falling 10% Or More

AJG ARE BAX BRO CAVA CMG DECK


Explainer: Is Tylenol safe to take during pregnancy?

Nov 3, 2025, 3:29 PM EST - 7 weeks ago

Explainer: Is Tylenol safe to take during pregnancy?

KMB


Kimberly-Clark to Buy Tylenol Maker Kenvue

Nov 3, 2025, 6:44 AM EST - 7 weeks ago

Kimberly-Clark to Buy Tylenol Maker Kenvue

KMB


Kimberly-Clark to acquire Kenvue in $48.7 billion deal

Nov 3, 2025, 6:36 AM EST - 7 weeks ago

Kimberly-Clark to acquire Kenvue in $48.7 billion deal

KMB


Kenvue Reports Third Quarter 2025 Results

Nov 3, 2025, 6:30 AM EST - 7 weeks ago

Kenvue Reports Third Quarter 2025 Results


Kenvue Declares Quarterly Cash Dividend

Oct 29, 2025, 6:45 AM EDT - 2 months ago

Kenvue Declares Quarterly Cash Dividend


Embattled ​Tylenol Maker Kenvue Hires New Marketing Chief

Oct 28, 2025, 3:23 PM EDT - 2 months ago

Embattled ​Tylenol Maker Kenvue Hires New Marketing Chief


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:50 PM
$KVUE Actionable Trade Alert: Market Context: $KVUE is currently trading at $17.21, showing a bullish sentiment as it is near its 60D high of $17.59. The RSI at 57.53 indicates that the stock is neither overbought nor oversold, suggesting room for upward movement. The MA30 at $16.92 and MA50 at $16.32 are both below the current price, reinforcing a bullish trend. Directional Bias: The stock is positioned well above its moving averages, indicating potential for continued upward momentum. With the recent high of $17.59, there is a clear target for profit-taking. Trade Plan: - Suggested Entry: $17.25 - Stop Loss: $16.75 (3% below entry) - Take Profit Targets: 1. $17.75 (2.9% gain) 2. $18.00 (4.3% gain) 3. $20.00 (16.5% gain) This plan offers a potential ROI of over 17% on the third target. Monitor the stock closely and adjust the stop loss as necessary. https://privateprofiteers.com
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 25 at 1:08 PM
no fomo on $KVUE - just waiting for H% to show low like usual
0 · Reply
Okadarlan
Okadarlan Dec. 25 at 11:24 AM
$KVUE Merry christmas everyone, vote against ... we dont need monopolies , i love the stock the way it is , the price and divi .. and their financials all are splended, nn no stupid merger, so all vote no please. Special Meeting of Kenvue Inc. Stockholders To be held at 9:00 a.m. Eastern Time on Thursday, January 29, 2026 Meeting Proposals Not Voted Vote by 11:59 p.m. ET on January 28, 2026 Documents to Review Before You Vote: Notice of Meeting ... Notice of Meeting and Proxy Statement(pdf) Please read the important information regarding this meeting agenda.
0 · Reply
nokej13957
nokej13957 Dec. 25 at 10:55 AM
0 · Reply
LaserLeverage
LaserLeverage Dec. 25 at 5:24 AM
$KVUE Future valuation dynamics revolve around resilience of demand as cyclical tailwinds fade, with outcomes shaped by timing and discipline. Failure to deliver could compress multiples quickly.
0 · Reply
1iquid
1iquid Dec. 25 at 3:33 AM
💎 Liquid® Live Actionable Trade Asset: $KVUE Contracts: $KVUE January 15, 2027 $18 Calls Scale in: $1.45- $1.77 Scale out: $5.63-$9.64 Profit Potential : 259% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
Suite510
Suite510 Dec. 25 at 3:20 AM
$JNJ $KVUE 1 Billion Bots 🤖 stupid lol 😂 Idiot corporate directors until they lose everything $JNJ $KVUE $SPY $SPX JNJ Insurance Company why pay millions on verdicts when you can pay Billions for 1 verdict 🤣🤓🍿
0 · Reply
Suite510
Suite510 Dec. 24 at 11:15 PM
$JNJ $KVUE Bear 🐻 ish can’t wait till 2026 😂🎅
0 · Reply
AbraKrak
AbraKrak Dec. 24 at 3:28 PM
$KMB Very happy with my buy @ 100 here. Not only is it undervalued, but a good hedge vs. any tech weakness. $KVUE
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Dec. 24 at 2:55 PM
$JNJ $KVUE $SPX $SPY FYI this account is a bot.
0 · Reply
Suite510
Suite510 Dec. 24 at 4:06 AM
$JNJ $KVUE $SPX $SPY Lawyer Who Got $1.5B Talc Verdict Against Johnson & Johnson: 'The Amount is Overwhelming' Jessica Dean, of Dallas-based Dean Omar Branham Shirley, talked to http://Law.com about the $1.5 billion talc verdict that jurors in Baltimore, Maryland, returned on Monday against Johnson & Johnson. December 23, 2025 Cheers 🥂 for the plaintiff
0 · Reply
Suite510
Suite510 Dec. 23 at 5:39 PM
$JNJ $KVUE $SPX 1.5B hairball lol JNJ Corporate and Legal bunch of clowns with the handling of Talc
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 23 at 2:28 PM
0 · Reply
Suite510
Suite510 Dec. 23 at 12:23 PM
$JNJ $KVUE $SPX $SPY lol 😂 from October 👋 Nice Christmas 🎁 JNJ corporate
0 · Reply
Suite510
Suite510 Dec. 23 at 12:17 PM
$JNJ $KVUE $SPX $SPY Bunch of idiots pumping this stock, just watch for a real bankruptcy or liquidation 😂 HEALTHCARE & PHARMACEUTICALS December 23, 2025 5:33 AM J&J vows appeal after US jury hits it with record $1.5 billion talc cancer award Cheers 🥂
1 · Reply
K3nley
K3nley Dec. 22 at 8:23 PM
$KVUE never ending red
0 · Reply
AbraKrak
AbraKrak Dec. 22 at 3:05 PM
$KMB Bought at 100. Looks undervalued, mostly influenced by negative sentiment over tylenol. $KVUE
0 · Reply
1iquid
1iquid Dec. 21 at 3:59 AM
💎 Liquid® Live Actionable Trade Asset: $KVUE Contracts: $KVUE January 15, 2027 $18 Calls Scale in: $1.49- $1.82 Scale out: $5.80-$9.95 Profit Potential : 55% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
1iquid
1iquid Dec. 20 at 3:02 PM
OptionWizards Tip (education only): Always define max loss before entering an options trade. $KVUE $LEN $KEYS Not financial advice.
0 · Reply
Suite510
Suite510 Dec. 20 at 12:23 PM
$JNJ $KVUE $SPX The boat is sinking again 😂 Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder Minnesota jury has awarded $65.5 million to a woman who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing mesothelioma ByThe Associated Press December 19, 2025, 8:38 PM
0 · Reply
risk_vs_reward
risk_vs_reward Dec. 19 at 8:33 PM
$BULL $KVUE $LUNR $TMC is currently trading at 82% discount VS its $23.6B Net Present Value!! 🤑 Deep sea mining by TMC is the MOAD (Mother Of All Disruptions) to mining. Way faster, cheaper, least carbon footprint. TMC will be the largest producer of nickel, cobalt and manganese and top 10 in copper. TMC is once in a lifetime investment opportunity- triple digit stock price in 3-4 years.
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 19 at 7:46 PM
Hedge Alert Live - Protect Your Portfolio Contract: $KVUE $17.00 Put · DEC 26, 2025 Exp Entry Price: $0.12 - $0.13 Exit Price Target: $0.24 Profit Margin: +100% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply